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We report on a reverse line blot (RLB) assay, utilizing fungal species-specific oligonucleotide probes to
hybridize with internal transcribed spacer 2 region sequences amplified using a nested panfungal PCR.
Reference and clinical strains of 16 Candida species (116 strains), Cryptococcus neoformans (five strains of
Cryptococcus neoformans var. neoformans, five strains of Cryptococcus neoformans var. grubii, and six strains of
Cryptococcus gatti), and five Aspergillus species (68 strains) were all correctly identified by the RLB assay.
Additional fungal species (16 species and 26 strains) not represented on the assay did not exhibit cross-
hybridization with the oligonucleotide probes. In simulated clinical specimens, the sensitivity of the assay for
Candida spp. and Aspergillus spp. was 100.5 cells/ml and 102 conidia/ml, respectively. This assay allows sensitive
and specific simultaneous detection and identification of a broad range of fungal pathogens.
The incidence of invasive fungal infections is increasing in
association with increasing populations of immunocompro-
mised and critically ill patients. Given that invasive fungal
infections are associated with high crude and attributable mor-
tality rates despite therapy with effective antifungal agents,
early diagnosis remains an important, but as yet unresolved,
challenge to potentially improve clinical outcomes. Deficien-
cies with current diagnostic approaches include poor specificity
(e.g., clinical and radiological features) and poor sensitivity
(e.g., blood cultures, which are rarely positive in invasive
aspergillosis and only 40 to 60% sensitive in invasive candidiasis)
(22). Furthermore, culture-based phenotypic identification
techniques are slow and especially prone to misidentification
of fungal pathogens, particularly uncommon species (22). De-
lays in identification have important clinical implications, given
the relative increase in the incidence of non-C. albicans Can-
dida spp. and the predictable intrinsic or relative fluconazole
resistance associated with certain Candida spp. such as Can-
dida krusei and Candida glabrata.
Molecular microbiological techniques have the potential to
achieve rapid, sensitive, and specific detection and identifica-
tion of fungi from clinical specimens or cultures. Although a
variety of targets, primers, and product detection methods has
been reported (2, 13), several challenges remain. Given the
diversity of human fungal pathogens, assays that amplify or
detect only one or a restricted number of fungal species have
limited utility. On the other hand, many panfungal assays have
no or limited species specificity (2, 13), which is problematic,
since species identification is important for therapeutic and
other clinical decisions. Although species-specific oligonucleo-
tide probes to identify panfungal PCR product have been re-
ported (2, 13), the challenge of incorporating this approach
into simple, inexpensive, and flexible formats that are readily
adaptable to the clinical microbiology laboratory remains.
To address these requirements, we describe the development
of a simple method to simultaneously detect and identify clinically
relevant fungal pathogens using a panfungal nested PCR followed
by hybridization with species-specific oligonucleotide probes in a
reverse line blot (RLB) assay.
MATERIALS AND METHODS
Fungal strains. Reference fungal strains were obtained from the American
Type Culture Collection, the Centraalbureau voor Schimmelcultures, and the
Molecular Mycology Research Laboratory at Westmead Hospital and clinical
isolates from the Mycology Laboratory at Westmead Hospital (Table 1). All
strains were characterized by colonial and microscopic morphology and physio-
logical testing using the VITEK I (bioMe´rieux Vitek, Hazelwood, Missouri)
and/or ID 32C (bioMe´rieux, Marcy-l’Etoile, France) commercial system. Clinical
strains were further characterized by sequencing of the internal transcribed
spacer region 1 (ITS1), 5.8S rRNA, and ITS2 regions.
Oligonucleotide design. Relevant fungal DNA sequences spanning the 5.8S
rRNA, ITS2, and 28S rRNA regions were accessed from GenBank and com-
pared using the Pileup and Pretty programs in the Multiple Sequence Analysis
program group provided in the Australia National Genomic Information Service
(ANGIS, 3rd version; accessed through http://biomanager.angis.org.au/).
Two pairs of primers, based on the universal fungal primers ITS3 and ITS4
(32) were designed for the nested amplification of the ITS2 region (Table 2). The
inner primer pair, designated ITS3B and ITS4B, were 5-end biotin labeled
(Sigma-Aldrich, Castle Hill, Australia).
Oligonucleotide probes targeting ITS2 sequences of Candida species were
modified (to increase their melting temperatures) from those described previ-
ously (5), and those of Aspergillus species and Cryptococcus neoformans were
designed (Table 2). All oligonucleotide probes were 5 end hexylamine labeled
(Sigma-Aldrich).
DNA extraction. Isolated yeast colonies or a small amount of fungal mycelial
mass was obtained from growth on Sabouraud’s dextrose agar incubated at 30°C
for 48 to 72 h and suspended in saline. DNA was extracted either directly or, for
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assessment of assay sensitivity, from dilutions of yeast cells or fungal mycelia in
EDTA-blood.
All reagents were obtained from Sigma-Aldrich or from BDH Laboratory
Supplies (Dorset, England). DNA extraction was performed in a class II laminar
flow cabinet using the GenElute mammalian genomic DNA kit (Sigma-Aldrich)
with some modifications. Briefly, 500 l of EDTA blood was mixed with 1.5 ml
of erythrocyte lysis buffer (0.155 M NH4Cl, 0.01 M NH4HCO3, and 0.1 mM
EDTA [pH 7.4]) (26) and incubated for 10 min at 20°C. Following centrifu-
gation (6,600 rpm for 10 min), the pellet was resuspended in 200 l of sorbitol
buffer (1 M sorbitol, 100 mM EDTA, 0.1% 2-mercaptoethanol) (33) with 200 U
of lyticase (Sigma-Aldrich) and incubated at 37°C for 60 min. Spheroplasts were
centrifuged (7,600 rpm for 5 min) and resuspended in 180 l of lysis solution T
and 20 l of proteinase K (Sigma-Aldrich), and then incubated at 55°C for 60
min. The DNA was then extracted according to the manufacturer’s instructions
in a final elution volume of 120 l. DNA was stored at 20°C before use.
ITS2 nested PCR conditions. The first-round PCR mixture (20 l) consisted of
125 M each dATP, aCTP, dGTP, and dTTP (Roche Diagnostics, Castle Hill,
Australia), 1 buffer (10 mM Tris-HCl [pH 8.3], 50 mM KCl, 1.5 mM MgCl2,
0.01% Tween 20, 0.01% [wt/vol] gelatin, and 0.01% Niaproof 4), 2.5 M each
outer primer (ITS3outer and ITS4outer), 0.5 U Taq DNA polymerase (Promega,
Annandale, Australia), and 5 l extracted genomic DNA. Amplification was
performed on an Eppendorf Mastercycler gradient thermocycler (Eppendorf
AG, North Ryde, Australia) for 30 cycles of denaturation at 94°C for 10 seconds,
annealing at 60°C for 10 seconds, and elongation at 74°C for 20 seconds. The
second-round PCR mixture (40 l) consisted of 125 M each deoxynucleotide,
1 buffer (as above), 2.5 M each inner primer (ITS3B and ITS4B), 1 U Taq
DNA polymerase, and 2 l of first-round product. The reaction conditions were
the same as for the first round except for an annealing temperature of 65°C.
Positive and negative controls were processed in parallel with each sample to
detect possible false-negative results and PCR contamination. The potential for
contamination was minimized by the use of dedicated equipment in separate
laboratory areas for each assay step as well as other standard measures (16).
Appropriately sized DNA bands (350 to 400 base pairs) were visualized fol-
lowing electrophoresis of 8 microliters of amplification product using a 2%
agarose gel and stained with 0.5 g/liter ethidium bromide.
Reverse line blot hybridization assay. The RLB hybridization assay was mod-
ified (31), based on a previously described method (29). In brief, the nylon
membrane-bound oligonucleotide probes were incubated with the PCR prod-
ucts. If present, the relevant PCR product hybridized with the probe and was
detected by chemiluminescence. The same membrane was able to be reused on
at least nine occasions following the stripping of bound PCR products without
loss of signal. The melting temperatures of the probes ranged between 60 and
80°C (Table 1) and the optimal hybridization temperature was determined to be
60°C. Serial dilutions of yeast cells and fungal mycelia were prepared in molec-
ular biology-grade water and added to whole blood to achieve final concentra-
tions ranging from 105 to 100 cells/ml. These were then extracted (as above) and
assayed to determine the sensitivity of the RLB assay.
ITS1 and ITS2 sequencing. The ITS1 and ITS2 regions of all clinical fungal
isolates were sequenced. In brief, a 250-l PCR mixture consisting of 5 l of
extracted genomic DNA, 2.5 mM each of dATP, dCTP, dGTP, and dTTP
(Roche Diagnostics, Germany), 1 GeneAmp PCR buffer (Applied Biosystems,
Melbourne, Australia), 5% glycerol, 10 M of forward (ITS1) and reverse (ITS4)
primers, and 1.25 U Taq DNA polymerase (Applied Biosystems) was amplified
on an Eppendorf Mastercycler (94°C for 2 min, 30 cycles of 94°C for 15 seconds,
55°C for 30 seconds, and 72°C for 30 seconds, followed by 72°C for 6 min). DNA
was purified using a commercial kit (GFX PCR DNA and gel band purification
kit, Amersham Biosciences, Castle Hill, Australia) according to the instructions.
The sequencing reactions were run using a POP6 polymer and 50-cm capillary
array on the ABI 3100 PRISM genetic analyzer (Applied Biosystems). Sequences
were edited using Chromas software, version 2.23, and compared with sequences
in GenBank using the FASTA nucleotide sequence search tool provided through
ANGIS.
RESULTS
Fifty-five reference strains and 177 clinical strains compris-
ing 40 fungal species were tested (Table 1). The universal
primers ITS3 and ITS4 amplified all strains. Results of iden-
tification by RLB and ITS1-2 sequencing were concordant for
all fungal strains represented on the RLB assay: 16 Candida
species (116 strains), Cryptococcus neoformans (five strains of
Cryptococcus neoformans var. neoformans, five strains of Cryp-
tococcus neoformans var. grubii, and six strains of Cryptococcus
gatti), and five Aspergillus species (68 strains). Predictable non-
specific hybridization occurred between Candida zeylanoides
DNA and the Candida guilliermondii oligonucleotide probe, as
previously described (5) but no other nonspecific hybridization
occurred (Fig. 1 and 2). DNA from one specimen, putatively
Candida glabrata, hybridized with both the Candida glabrata
and Candida parapsilosis probes but failed to yield an accurate
TABLE 1. Reference and clinical strains used in the RLB assay





C. albicans 3 (ATCC 90028, CBS 562) 14
C. dubliniensis 1 (CBS 7988) 9
C. glabrata 2 (ATCC 90030, CBS 138) 8
C. guilliermondii 3 (CBS 2030, CBS 2031, CBS 5256) 10
C. haemulonii 1 (CBS 5149) 3
C. kefyr 3 (ATCC 4135, CBS 834, CBS 712) 1
C. krusei 1 (CBS 6258) 9
C. lusitaniae 5 (CBS 5305, CBS 5901, CBS 5094,
CBS 4413, CBS 6936)
9
C. norvegica 1 (CBS 4239) 0
C. parapsilosis (group I) 1 (ATCC 22019) 14
C. pelliculosa 2 (CBS 605 CBS 5759) 0
C. rugosa 0 1
C. tropicalis 0 14
C. utilis 2 (CBS 621 CBS 1600) 0
C. viswanathii 1 (CBS 4024) 1
C. zeylanoides 1 (CBS 619) 1
C. famata 1 (CBS 940) 0
C. holmii 1 (CBS 135) 0
C. lipolytica 3 (CBS 6124, CBS 599,
MMRL 210B)
0
C. norvegenisis 2 (CBS 6564 CBS 6403) 0
C. pulcherrima 0 1
Cryptococcus speciesa
C. neoformans var. grubii 5 (GI (VNI), LA 404 (VNII),





5 (CDCR 461 (VNIV) KRIMM 2
(VNIV) CBS 7816 (VNIV)
WM 01.84 (VNIV) WM 01.85
(VNIV))
0
C. gattii 6 (4A (VGI) 4B (VGI) 4C (VGI)
10A (VGI) 10B (VGI) 4A (VGI))
0
Other yeast species
Saccharomyces cerevisiae 1 (CBS 1907) 1
Aspergillus species
A. flavus 1 (ATCC 204304) 12
A. fumigatus 1 (ATCC 204305) 12
A. nidulans 0 10
A. niger 0 18
A. terreus 0 14
A. candidus 0 1
Other mold species
Scedosporium prolificans 0 2
S. apiospermum 0 2
Penicillium citrinum 0 1
P. chrysogenum 1 (AMMRL 42.29) 0
P. brevicompactum 1 (AMMRL 42.26) 0
P. aurantiogriseum 1 (AMMRL 42.28) 0
Eurotium amstelodamii 1 (AS107) 0
Trichophyton mentagrophytes 0 5
Trichophyon rubrum 0 3
Microsporum gypseum 0 1
Total 56 176
a See reference 21 for designations of molecular types of C. neoformans.










identification by ITS1-2 sequencing: further examination of
cultures on chromogenic agar (CHROMagar Candida, Dutec
Diagnostics, Croydon, Australia) demonstrated two colonial
morphologies, which on phenotypic testing revealed a mixed
culture, confirming the RLB result. On ITS sequencing, all
Candida parapsilosis strains were determined to represent
those from Candida parapsilosis group I (27). DNA from fun-
gal species not represented on the RLB assay (16 species and
26 strains) and all negative controls failed to hybridize with any
of the probes.
The RLB assay reliably yielded positive results from whole-
blood samples containing 100.5 yeasts/ml for Candida spp. (and
on at least 50% of occasions with 100/ml), and 102 conidia/ml
for Aspergillus spp. The sensitivity of a band on the RLB assay
was generally 10-fold higher than visualization under UV light
following gel electrophoresis and ethidium bromide staining.
DISCUSSION
This RLB assay is able to detect and identify a diverse range
of clinically relevant fungal pathogens, including major Can-
dida, Aspergillus, and Cryptococcus species, by hybridizing the
PCR product amplified using panfungal primers with mem-
brane-bound species-specific oligonucleotide probes. Given
the diverse range of potential human fungal pathogens and the
importance of species identification for therapeutic and other
clinical decisions, the competing requirements for molecular
assays include broad-range fungal detection and species-spe-
cific identification. Although multiplex assays using species-
specific primers are able to identify species, their utility is
limited by the number of primers able to be incorporated.
Panfungal assays, on the other hand, are potentially able to
detect all fungal pathogens, but require additional techniques
for their identification. This has been achieved using PCR
product sequencing (9, 11, 14), although this remains relatively
costly, time-consuming, and potentially inaccurate in the pres-
ence of mixed fungal species. Other methods, such as differ-
ences in PCR product sizes following electrophoresis, restric-
tion fragment length polymorphism analysis, or single-stranded
conformational polymorphism analysis (2, 13), have been used
but are not sequence specific and may not be readily adapted
for use in the clinical microbiology laboratory.
The use of a panfungal PCR followed by hybridization with
species-specific probes is a practical solution to these limitations.
Detection of oligonucleotide probe hybridization has been re-
ported using microtitration plate-based enzyme immunoassay (5,
17, 30), Southern or slot blotting (4, 6, 23, 28), and fluorogenic
probes (8, 19, 24). We chose the RLB format, given the advan-
tages of relative simplicity, low cost, ready availability of the ma-
terials and the methods, and ability to simultaneously analyze
multiple specimens against multiple probes (7). This approach
has been reported previously using a proprietary line probe assay
TABLE 2. Oligonucleotide primers and probes
Primer or
probe Target Tm (°C)
a GenBank
accession no. Sequence (5 to 3)
b
Primers
ITS1 18S rRNA universal fungal 5 primer 68.4 AF455531 19TCC GTA GGT GAA CCT GCG G37
ITS3 outer 5.8S rRNA universal fungal 5 outer primer 76.62 AF455531 200CGG ATC TCT TGG C/TTC/T C/TG/CA/G CAT CGA
TGA AGA ACG232
ITS3Bc 5.8S rRNA universal fungal 5 inner primer 73.0 AF455531 210GGC/T TC/TC/T G/CA/GC ATC GAT GAA GAA CGC
AGC236
ITS4Bc 28S rRNA universal fungal 3 inner primer 72.9 L28817 741GTT GGT TTC TTT TCC TCC GCT TAT TGA TAT
GC710
ITS4 outer 28S rRNA universal fungal 3 outer primer 79.96 L28817 751GGC AAT CCC TGT TGG TTT CTT TTC CTC CGC
TTA TTG716
Probesd
CA ITS2 region of C. albicans 74.3 AF455531 456ATT GCT TGC GGC GGT AAC GTC C477
DB ITS2 region of C. dubliniensis 79.5 AJ249485 443AAG GCG GTC TCT GGC GTC GCC C465
CGE ITS2 region of C. glabrata 62.2 AF167993 715TTT ACC AAC TCG GTG TTG ATC T736
GU ITS2 region of C. guilliermondii 69.9 AF455495 510CCC GGC CTT ACA ACA ACC AAA C531
CH ITS2 region of C. haemulonii 64.5 U70501 19CCG TTG GTG GAT TTG TTT CTA A40
KF ITS2 region of C. kefyr 64.1 AJ401701 557GAG ACT CAT AGG TGT TAT AAA GAC TCG C584
CK ITS2 region of C. krusei 65.5 AF246989 406GGC CGA GCG AAC TAG ACT TTT427
LU ITS2 region of C. lusitaniae 71.2 AF009215 279CTC CGA AAT ATC AAC CGC GCT G300
NC ITS2 region of C. norvegica 75.6 U70508 119ACG AGC GTC TGC TGG CTC CAC A140
CP ITS2 region of C. parapsilosis 61.4 AF455530 483ACA AAC TCC AAA ACT TCT TCC A504
PL ITS2 region of C. pelliculosa 60.4 AF321543 502ATC AGC TAG GCA GGT TTA GAA G523
CR ITS2 region of C. rugosa 62.9 AF218971 189CAG TTA AGC TTG TTA CAG ACT CAC G213
CT ITS2 region of C. tropicalis 65.0 L47112 426AAC GCT TAT TTT GCT AGT GGC C447
CU2 ITS2 region of C. utilis 65.5 AF458091 430CCA ACT CGT TAT TTT CCA GAC AGA C454
VS ITS2 region of C. viswanathii 65.6 AY139792 148CTA CCA AAA CGC TTG TGC AGT C169
CZ ITS2 region of C. zeylanoides 61.3 AF218976 256TCG TTG ACC AGT ATA GTA TTT GTT TAT TAC285
CNEO ITS2 region of C. neoformans 64.9 AJ493561 426 TAT GGG GTA GTC TTC GGC TTG 446
AFUM ITS2 region of A. fumigatus 65.29 AY660923 140 AGC CGA CAC CCA ACT TTA TTT TT 162
AFL ITS2 region of A. flavus 66.77 AF454111 147 ACG CAA ATC AAT CTT TTT CCA GG 169
ANID ITS2 region of A. nidulans 65.1 AY660924 142 GGC GTC TCC AAC CTT ATT TTT CT 164
ANIG ITS2 region of A. niger 67.88 AF454120 141 GCC GAC GTT TTC CAA CCA TT 160
ATER ITS2 region of A. terreus 66.58 AF454134 148 GCA TTT ATT TGC AAC TTG TTT TTT TCC 174
a Melting temperatures as provided by the oligonucleotide synthesizer (Sigma Aldrich, Castle Hill, Australia).
b Boldface numbers represent the numbered base positions at which the primer or probe sequence starts and finishes (starting at point 1 of the corresponding
GenBank sequence). Underlined sequences show bases added to modify previously published primers or probes.
c Inner primers were 5 biotin labeled.
d All probes were 5 hexylamine labeled.










with ITS1 probes for eight yeast and three Aspergillus species (20).
Our assay extends this to 17 yeast species and five Aspergillus
species. Additional advantages of our method include the capac-
ity to assay up to 43 specimens in a single run and for the mem-
brane to be reused up to nine times without loss of signal. Fur-
thermore, although 23 species-specific probes were used in the
present assay, up to 43 can be included on the same membrane,
providing the flexibility and capacity to simultaneously detect and
identify other fungal or nonfungal microbial pathogens, antimi-
crobial resistance genes, or microbial virulence genes. Finally, this
membrane-based format can be adapted to a DNA microarray
format.
On the basis of ITS sequences, all Candida parapsilosis
strains included in this study were from group I. The ability of
the Candida parapsilosis probe (CP) to hybridize with Candida
parapsilosis groups II and II (recently proposed as new species
Candida orthopsilosis and Candida metapsilosis respectively)
(27) remains uncertain, although it exhibited 22 of 22, 17 of 22,
and 20 of 22 sequence homology with the ITS2 region of
Candida parapsilosis groups I, II, and III, respectively. The
Cryptococcus neoformans probe (CNEO) was designed on con-
served sequences and thus hybridized with Cryptococcus neo-
formans var. neoformans, Cryptococcus neoformans var. grubii,
and Cryptococcus gattii.
Although a single amplification round of the panfungal PCR
was sufficient for DNA extracted directly from cultures, the
nested format maximizes detection limits for DNA extracted
directly from clinical specimens. In this regard, the sensitivity
of this assay appears promising, as PCR product from DNA
extracted from 500-l aliquots of simulated clinical specimens
containing 100.5 Candida cells/ml of whole blood was reliably
detected and identified. Further, from more than half of spec-
imens, 100 Candida cells/ml were detected. This level of sen-
sitivity will be clinically useful for Candida species, given the
postulated fungal loads in invasive candidiasis of 1 CFU/ml
in approximately 36% of candidemic cases and 1 to 10 CFU/ml
in another 28% (1) and is comparable to the limits of detection
reported previously using panfungal assays and oligonucleotide
probes (4, 10, 20, 25, 28). The sensitivity for Aspergillus species
was 102 conidia/ml, similar to that reported elsewhere (3).
Although not encountered in this study, environmental and
carryover contamination remains a potential problem associ-
ated with nested panfungal PCR assays. However, as the hy-
bridization of PCR product with species-specific probes is de-
tected visually, the possibility of contamination may be
suggested by hybridization with the same probe across multiple
samples. Mixed fungal species infections are suggested by hy-
bridization with multiple probes in individual samples.
The multicopy ribosomal gene complex is a useful target for
this assay for reasons of sensitivity, high sequence conservation
of its 18S, 5.8S, and 28S regions (for panfungal primers), and
high variability of its intervening ITS regions (for species-
specific probes) with high interspecies and low intraspecies
heterogeneity (12, 15, 18). The probes in the present assay
were highly specific and differentiated all species unambigu-
ously, apart from the cross-reactivity between the Candida
FIG. 1. RLB. Positions of species-specific probes are shown on the
left-hand side (abbreviations, Table 2). The ITS2 PCR amplicons are
shown in lanes 1 to 42 and include two strains of each species except
for one strain of Candida norvegica (lane 27), one strain of Candida
famata (lane 38: no hybridization) and four strains of Cryptococcus
neoformans (lanes 39 to 42).
FIG. 2. RLB. Positions of species-specific probes are shown on the
left-hand side (abbreviations, Table 2). The ITS2 PCR amplicons are
shown in lanes 1 to 22 and include Candida haemuloni (lane 1), Can-
dida pelliculosa (lanes 2 and 3), Candida zeylanoides (lanes 4 and 6),
Candida viswanathii (lanes 5 and 11), Candida famata (lane 7), Can-
dida lipolytica (lane 8), A. fumigatus (lanes 9 and 10), Candida albicans
(lanes 12 to 15), Candida glabrata (lane 16), Candida guilliermondii
(lane 17), Penicillium citrinum (lane 18), Candida rugosa (lane 19),
Candida norvegica (lane 20), Candida dubliniensis (lane 21), and Can-
dida kefyr (lane 22). Hybridization between Candida zeylanoides DNA
(lanes 4 and 6) and both the CZ and GU probes.










guilliermondii probe and Candida zeylanoides DNA product
noted previously (5).
The major limitation of this assay and other molecular assays
is time. A full working day is required for DNA extraction
(relatively fixed for all assays, approximately 3 h), nested PCR
(approximately 3 h), and product detection and identification
using the RLB assay (approximately 3 h). We minimized the
time required for the PCR by redesigning the panfungal prim-
ers ITS3 and ITS4 to allow high annealing temperatures and
short cycle times. Although amplification times can be some-
what reduced by real-time PCR techniques, species identifica-
tion is limited by the number of fluorogenic probes that are
able to be incorporated.
We will now evaluate this assay on clinical specimens, par-
ticularly whole blood, to determine its utility in the early diag-
nosis of invasive fungal infections compared with traditional
culture-based techniques.
In conclusion, this study demonstrates the accuracy and po-
tential utility of a panfungal molecular assay for the simulta-
neous detection and identification of a diverse range of clini-
cally important fungal pathogens.
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